Articles linked to patient safety issues
Please find all related articles below.
The projected shortage of over 1 million health workers by 2020 represents a serious threat to health systems in Europe. Continued action on health workforce is essential across the EU as professional imbalances can lead to growing health disparities within and between countries. Europe’s health workforce policies also have a major impact on neighbouring countries and on a global scale.
The implementation of the Action Plan for the EU Health Workforce is progressing with two key (...)
The 20th congress of EPHA member the European Association of Hospital Pharmacists (EAHP) took place in Hamburg on 25-27 March 2015. This year’s focus was ’patient safety first’, and various sessions explored how hospital pharmacists can contribute to the patient journey, for example by ensuring medication reconciliation and safety and by providing expert advice on treatments and medicines.
EPHA President Peggy Maguire - also Director General of the European Institute of (...)
In December 2014, the European Commission launched the latest public consultation on the review of the Working Time Directive 2003/88/EC in the hope to make progress following the failed negotiations of the cross-sectoral social partners at the end of 2012.
The Commission’s declared goal is to consider making appropriate changes that would make the Directive more suitable for dealing with the ongoing challenges Europe’s employment sectors are subject to. The outcomes of the (...)
European Ministers of Health also adopted conclusions on innovation for the benefit of patients at a Council meeting on 1 December 2014. Ministers are calling on national governments and the European Commission to cooperate more closely on the ’life cycle approach’ for new innovative medicines and move ahead with the implementation of health technology assessment.
The Council conclusions highlight the importance of early dialogue between technology developers, regulatory, (...)
In recent years, antimicrobial resistance (AMR) has been identified as a major health threat. The 2014 European Antibiotic Awareness Day drew attention to the consequences arising from the overuse and misuse of antibiotics, for instance through self-medication.
The emergence of multi-drug resistant ’superbugs’ as a result is a serious threat to health throughout Europe.
European Health Ministers recently issued Council conclusions which expand the EU level discourse about (...)
28 October 2014, Brussels – MEPs, patients and the European public health community are today asking President-elect Juncker to clarify whether medical devices and health technologies will remain in the directorate for health or not. Fears over patient safety remain as Mr Juncker has so far failed to publicly clarify his ambiguous statement (1) last week to the European Parliament.
Last week’s statement of the European Commission’s President-elect that the competence for (...)
Further to our Joint Letter of 16 September 2014 (1) , we are contacting you again to express our gratitude for your decision (2) to move the competence for medicines and pharmaceutical products back into the hands of the European Commissioner for Health. We firmly believe that this directorate is best placed to ensure a good balance between economic and public health objectives while promoting ‘smart, sustainable and inclusive’ growth for Europe.
28 October 2014, Brussels (...)
More integrated prevention and care models have long been recognised as important elements in moving towards better quality and sustainability in healthcare, in particular in view of the rising burden of non-communicable diseases and demographic change, and the complexities of multiple morbidities that this brings.
By Sascha Marschang, EPHA Policy Manager for Health Systems and Milena Richter, Senior Director European Public Affairs, Sanofi.
While healthcare systems move towards (...)
22 July 2014 - Following in-depth discussions with members, EPHA responded to the European Commission’s public consultation on its Green Paper on mobile health (mHealth) in early July. In its response, EPHA emphasises that mHealth development should not only be seen as a way to gain cost efficiencies, but that relevant solutions - including smartphone applications - must first and foremost aim to bring concrete benefits for different types of end users including patients and health (...)
Ageing and Older People
Health Rights and Patients
As a fundamental pillar of the social and welfare model that defines and strengthens European identity, a solid health workforce is a public resource that must be secured at the local, national and global levels. Therefore EPHA supports the HW4All initiative with its goal of reinforcing the ethical guidelines outlined in the 2010 WHO Global Code of Practice on the International Recruitment of Health Personnel.
On 15 and 16 July, EPHA attended separate meetings with (...)